Today’s top gainers include the company Perrigo Company plc (NYSE:PRGO) which is in the industry Drug Related Products, gaining 2.52% today. In the last week its performance is -6.98%, and -3.49% for the past quarter. Currently, Perrigo Company plc, PRGO has a target price of 117.31, so today’s gain of 2.52% is a significant step towards its target price. The GAP today is therefore 0.22%.
Perrigo Company plc (NYSE:PRGO), has a market cap of 12204.19, and is based in Ireland. Insider ownership is at 0.20%, and institutional ownership is 76.70%.
At the current price of 87.96, it has a dividend yield of 0.68%, and its target price is 117.31. This is with a profit margin of -3.80%, and total debt/equity of 0.66. Perrigo Company plc (NYSE:PRGO) has a P/E of *TBA, as well as a forward P/E of 9.48.
With a current EPS of -1.91, and a forecasted EPS growth for next year at 10.49%,Perrigo Company plc (NYSE:PRGO) has had a EPS growth for the past five years at -59.80%. For the next five years EPS growth is projected to be 7.98%.
Performance for the year is -53.69%. Since its IPO date on 12/17/1991, the total performance to date is -40.55%.
Volume today for Perrigo Company plc (NYSE:PRGO), is 3571588, while its average volume is 2452.41. Whilst the total gain today was 2.52%, it did have a day high of -20.76%.
Volatility for this week has been at 2.34%, and 2.35% for the month. The 52-week low for Perrigo Company plc, PRGO has been 6.62%, while the 52-week-high has reached -55.48%.
Looking at its return of investments, which is 0.80%, and its return on assets is -1.10%. Perrigo Company plc (NYSE:PRGO) has an operating margin of -0.40%. With a sales growth of 31.80% quarter over quarter. Bearing in mind that Perrigo Company plc, PRGO is in the sector Healthcare, its long-term debt/equity is 0.6, and has a current ratio of 1.4 and 1 for quick ratio.
So what is the value of Perrigo Company plc? Well its PEG is *TBA, and the P/S is 2.15, along with a P/B of 1.25. Meanwhile it has a p/cash of *TBA.